Skip to Main Content
Skip Nav Destination

Taking CEE Alone Can Up Risk of Ovarian Cancer

May 23, 2024

After 20 years of follow-up, Women’s Health Initiative researchers have found that women who took menopausal hormone therapy—specifically conjugated equine estrogen (CEE) alone—were twice as likely to develop ovarian cancer and nearly three times as likely to die from the disease as those who took CEE with progesterone. The data also showed that those who received the drug combination had a 28% lower risk of developing uterine cancer than those who received only CEE, although their risk of dying from that disease didn’t drop. In sharing their work with the media in advance of the American Society of Clinical Oncology 2024 Annual Meeting, which begins on May 31, researchers emphasized the absolute risk of ovarian cancer is low and that estrogen formulations other than CEE are used more often today than when the study began.

Close Modal

or Create an Account

Close Modal
Close Modal